Diabetes Drugs Market Report

Global and Region Diabetes Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：203
  • REPORT CODE：GMM908293
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Diabetes occurs when the body does not produce enough insulin or insulin at all. There is no cure and the disease can cause serious health problems with age.

    North America is expected to have a significant market share over the forecast period. The rising prevalence of diabetes in the United States has prompted local companies to work hard to develop new and affordable drugs for patients. The market will be valued at US$ 78,261.8 million by the end of 2026, thereby exhibiting a CAGR of 6% from 2020-2026.

    The growing awareness of diabetes and anti-diabetic drugs in North America will contribute to the growth of the global diabetes drug market. In addition, the continued approval of new drugs also contributes to the growth of the global diabetes drug market. However, the costs associated with treating diabetes with insulin may hinder the market growth.

    The report details the trend, potential and market size of Diabetes Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Diabetes Drugsmarket, defines the market attractiveness level of Diabetes Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Diabetes Drugs industry, describes the types of Diabetes Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diabetes Drugs market and the development prospects and opportunities of Diabetes Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diabetes Drugs market in Chapter 13.

    By Player:

    • JUMCAN(SK)

    • AstraZeneca

    • Kelun(US)

    • Bayer

    • Yiling(US)

    • Dongbao(IT)

    • Sanofi(DE)

    • NCPC(US)

    • Hisun(DE)

    • Gan & Lee(US)

    • Taloph(US)

    • HUADONG MEDICINE(DE)

    • Boehringer Ingelheim

    • Wanbang(IT)

    • Takeda

    • Novo Nordisk(US)

    • Novartis(US)

    • Eli Lilly(UK)

    • Johnson & Johnson

    • Merck

    By Type:

    • Insulin

    • Receptor Agonists

    • Inhibitors

    • Others

    By End-User:

    • Injection

    • Oral

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Diabetes Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Diabetes Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Diabetes Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Diabetes Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Diabetes Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Diabetes Drugs Consumption (2017-2022)

    • 7.2 United States Diabetes Drugs Consumption (2017-2022)

    • 7.3 Europe Diabetes Drugs Consumption (2017-2022)

    • 7.4 China Diabetes Drugs Consumption (2017-2022)

    • 7.5 Japan Diabetes Drugs Consumption (2017-2022)

    • 7.6 India Diabetes Drugs Consumption (2017-2022)

    • 7.7 South Korea Diabetes Drugs Consumption (2017-2022)

    8 Region and Country-wise Diabetes Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Diabetes Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Diabetes Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Diabetes Drugs Consumption Forecast (2022-2028)

    • 8.4 China Diabetes Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Diabetes Drugs Consumption Forecast (2022-2028)

    • 8.6 India Diabetes Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Diabetes Drugs Consumption Forecast (2022-2028)

    9 Global Diabetes Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Diabetes Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Receptor Agonists Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Diabetes Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Injection Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oral Consumption and Growth Rate (2017-2022)

    10 Global Diabetes Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Diabetes Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Diabetes Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)

    11 Global Diabetes Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Diabetes Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Diabetes Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Diabetes Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Diabetes Drugs Market Competitive Analysis

    • 14.1 JUMCAN(SK)

      • 14.1.1 JUMCAN(SK) Company Details

      • 14.1.2 JUMCAN(SK) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 JUMCAN(SK) Diabetes Drugs Product and Service

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Details

      • 14.2.2 AstraZeneca Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca Diabetes Drugs Product and Service

    • 14.3 Kelun(US)

      • 14.3.1 Kelun(US) Company Details

      • 14.3.2 Kelun(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Kelun(US) Diabetes Drugs Product and Service

    • 14.4 Bayer

      • 14.4.1 Bayer Company Details

      • 14.4.2 Bayer Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bayer Diabetes Drugs Product and Service

    • 14.5 Yiling(US)

      • 14.5.1 Yiling(US) Company Details

      • 14.5.2 Yiling(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Yiling(US) Diabetes Drugs Product and Service

    • 14.6 Dongbao(IT)

      • 14.6.1 Dongbao(IT) Company Details

      • 14.6.2 Dongbao(IT) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Dongbao(IT) Diabetes Drugs Product and Service

    • 14.7 Sanofi(DE)

      • 14.7.1 Sanofi(DE) Company Details

      • 14.7.2 Sanofi(DE) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi(DE) Diabetes Drugs Product and Service

    • 14.8 NCPC(US)

      • 14.8.1 NCPC(US) Company Details

      • 14.8.2 NCPC(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 NCPC(US) Diabetes Drugs Product and Service

    • 14.9 Hisun(DE)

      • 14.9.1 Hisun(DE) Company Details

      • 14.9.2 Hisun(DE) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Hisun(DE) Diabetes Drugs Product and Service

    • 14.10 Gan & Lee(US)

      • 14.10.1 Gan & Lee(US) Company Details

      • 14.10.2 Gan & Lee(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Gan & Lee(US) Diabetes Drugs Product and Service

    • 14.11 Taloph(US)

      • 14.11.1 Taloph(US) Company Details

      • 14.11.2 Taloph(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Taloph(US) Diabetes Drugs Product and Service

    • 14.12 HUADONG MEDICINE(DE)

      • 14.12.1 HUADONG MEDICINE(DE) Company Details

      • 14.12.2 HUADONG MEDICINE(DE) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 HUADONG MEDICINE(DE) Diabetes Drugs Product and Service

    • 14.13 Boehringer Ingelheim

      • 14.13.1 Boehringer Ingelheim Company Details

      • 14.13.2 Boehringer Ingelheim Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Boehringer Ingelheim Diabetes Drugs Product and Service

    • 14.14 Wanbang(IT)

      • 14.14.1 Wanbang(IT) Company Details

      • 14.14.2 Wanbang(IT) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Wanbang(IT) Diabetes Drugs Product and Service

    • 14.15 Takeda

      • 14.15.1 Takeda Company Details

      • 14.15.2 Takeda Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Takeda Diabetes Drugs Product and Service

    • 14.16 Novo Nordisk(US)

      • 14.16.1 Novo Nordisk(US) Company Details

      • 14.16.2 Novo Nordisk(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Novo Nordisk(US) Diabetes Drugs Product and Service

    • 14.17 Novartis(US)

      • 14.17.1 Novartis(US) Company Details

      • 14.17.2 Novartis(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Novartis(US) Diabetes Drugs Product and Service

    • 14.18 Eli Lilly(UK)

      • 14.18.1 Eli Lilly(UK) Company Details

      • 14.18.2 Eli Lilly(UK) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Eli Lilly(UK) Diabetes Drugs Product and Service

    • 14.19 Johnson & Johnson

      • 14.19.1 Johnson & Johnson Company Details

      • 14.19.2 Johnson & Johnson Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Johnson & Johnson Diabetes Drugs Product and Service

    • 14.20 Merck

      • 14.20.1 Merck Company Details

      • 14.20.2 Merck Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Merck Diabetes Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Diabetes Drugs

    • Figure Diabetes Drugs Picture

    • Table Global Diabetes Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diabetes Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Diabetes Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Diabetes Drugs Consumption by Country (2017-2022)

    • Figure United States Diabetes Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Diabetes Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Diabetes Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Diabetes Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Diabetes Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Diabetes Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Diabetes Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Diabetes Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Diabetes Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Diabetes Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Diabetes Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Diabetes Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Receptor Agonists Consumption and Growth Rate (2017-2022)

    • Figure Global Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Receptor Agonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Diabetes Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Diabetes Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table JUMCAN(SK) (Foundation Year, Company Profile and etc.)

    • Table JUMCAN(SK) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table JUMCAN(SK) Diabetes Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Diabetes Drugs Product and Service

    • Table Kelun(US) (Foundation Year, Company Profile and etc.)

    • Table Kelun(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kelun(US) Diabetes Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Diabetes Drugs Product and Service

    • Table Yiling(US) (Foundation Year, Company Profile and etc.)

    • Table Yiling(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yiling(US) Diabetes Drugs Product and Service

    • Table Dongbao(IT) (Foundation Year, Company Profile and etc.)

    • Table Dongbao(IT) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongbao(IT) Diabetes Drugs Product and Service

    • Table Sanofi(DE) (Foundation Year, Company Profile and etc.)

    • Table Sanofi(DE) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi(DE) Diabetes Drugs Product and Service

    • Table NCPC(US) (Foundation Year, Company Profile and etc.)

    • Table NCPC(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table NCPC(US) Diabetes Drugs Product and Service

    • Table Hisun(DE) (Foundation Year, Company Profile and etc.)

    • Table Hisun(DE) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hisun(DE) Diabetes Drugs Product and Service

    • Table Gan & Lee(US) (Foundation Year, Company Profile and etc.)

    • Table Gan & Lee(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gan & Lee(US) Diabetes Drugs Product and Service

    • Table Taloph(US) (Foundation Year, Company Profile and etc.)

    • Table Taloph(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taloph(US) Diabetes Drugs Product and Service

    • Table HUADONG MEDICINE(DE) (Foundation Year, Company Profile and etc.)

    • Table HUADONG MEDICINE(DE) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table HUADONG MEDICINE(DE) Diabetes Drugs Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Diabetes Drugs Product and Service

    • Table Wanbang(IT) (Foundation Year, Company Profile and etc.)

    • Table Wanbang(IT) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wanbang(IT) Diabetes Drugs Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Diabetes Drugs Product and Service

    • Table Novo Nordisk(US) (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk(US) Diabetes Drugs Product and Service

    • Table Novartis(US) (Foundation Year, Company Profile and etc.)

    • Table Novartis(US) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis(US) Diabetes Drugs Product and Service

    • Table Eli Lilly(UK) (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly(UK) Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly(UK) Diabetes Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Diabetes Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Diabetes Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Diabetes Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US